LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Deferred Income Tax Liabilities, Net in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Lifecore Biomedical, Inc. \De\ quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q2 2019 to Q3 2024.
  • Lifecore Biomedical, Inc. \De\ Deferred Income Tax Liabilities, Net for the quarter ending August 25, 2024 was $443K, a 2.85% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $443K -$13K -2.85% Aug 25, 2024 10-Q 2024-10-04
Q2 2024 $543K +$163K +42.9% May 26, 2024 10-Q 2024-10-04
Q1 2024 $607K +$527K +659% Feb 25, 2024 10-Q 2024-08-09
Q4 2023 $416K +$406K +4060% Nov 26, 2023 10-Q 2024-08-09
Q3 2023 $456K +$332K +268% Aug 27, 2023 10-Q 2024-08-09
Q2 2023 $380K +$254K +202% May 28, 2023 10-K 2024-08-26
Q1 2023 $80K -$716K -90% Feb 26, 2023 10-K 2024-03-20
Q4 2022 $10K -$1.19M -99.2% Nov 27, 2022 10-K 2024-03-20
Q3 2022 $124K -$3.83M -96.9% Aug 28, 2022 10-K 2024-03-20
Q2 2022 $126K -$5.85M -97.9% May 29, 2022 10-K 2024-03-20
Q1 2022 $796K -$5.31M -87% Feb 27, 2022 10-K 2024-03-20
Q4 2021 $1.2M -$5.43M -81.9% Nov 28, 2021 10-K 2024-03-20
Q3 2021 $3.95M -$4.93M -55.5% Aug 29, 2021 10-K 2024-03-20
Q2 2021 $5.98M -$7.61M -56% May 30, 2021 10-K 2024-03-20
Q1 2021 $6.1M -$5.56M -47.7% Feb 28, 2021 10-K 2024-03-20
Q4 2020 $6.63M -$10.4M -61.1% Nov 29, 2020 10-K 2024-03-20
Q3 2020 $8.88M -$8.81M -49.8% Aug 30, 2020 10-K 2024-03-20
Q2 2020 $13.6M -$5.81M -29.9% May 31, 2020 10-K 2021-07-29
Q1 2020 $11.7M Feb 23, 2020 10-Q 2020-04-03
Q4 2019 $17M Nov 24, 2019 10-Q 2020-01-02
Q3 2019 $17.7M Aug 25, 2019 10-Q 2019-10-03
Q2 2019 $19.4M May 26, 2019 10-K 2020-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.